The global viral clearance market size is expected to reach USD 1,967.68 Million by 2028 at a CAGR of 21.9%, according to the latest report by Reports and Data. Key factors driving market revenue growth include growing global healthcare burden due to increasing prevalence of chronic diseases, increasing private and public funding for biopharmaceutical RD, rising demand for biologics, and rapid rise in drug discovery and development processes. Technological advancements in nanofiltration and other viral removal methods are also expected to contribute significantly to revenue growth of the market over the forecast period.
Viral clearance entails removal of viral contamination from biological products with the application of customized membranes or chromatography. Viral contamination is a common complication of majority human- and animal-derived biopharmaceuticals. Viruses can be accidently introduced into the manufacturing processes of biological products and can originate from cell lines, cell culture media or from equipment. It is imperative to perform viral testing studies and integrate viral clearance methods into manufacturing processes. Viral clearance studies are an important part of process validation and ensuring safety of drugs. Biopharmaceutical manufacturers have devised alternative methods to overcome viral contaminations caused by cell lines or culture media and this is expected to be a key factor driving market revenue growth over the forecast period.
Viral clearance plays a crucial role in development processes for monoclonal antibodies, recombinant proteins, tissue and blood derived products, and medical devices. It is important to recognize which viruses can potentially contaminate a product and enter its manufacturing processes and this has boosted demand for efficient viral-clearance validation processes. This is expected to drive market growth over the forecast period. However, high costs associated and lengthy drug development processes are expected to restrain market growth to a certain extent over the forecast period.
Top Companies Profiled in the Report Include:
Charles River Laboratories International, Inc., WuXi Biologics, Lonza Group, Merck KGaA, Sigma-Aldrich Corporation, Avance Biosciences Inc., BSL BIOSERVICE, Clean Cells, SGS S.A., Texcell, Inc., and Vironova Biosafety.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4001
Market Overview:
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/4001
The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, RD activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.
The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Viral Clearance market in these key regions.
Country-wise regional analysis covers:
· North America
· Europe
· Asia Pacific
· Latin America
· Middle East Africa
To know more about the report @ https://www.reportsanddata.com/press-release/global-viral-clearance-market
Additionally, the report consists a detailed analysis of the segmentation of the Viral Clearance market based on product types and end-use/application offered in the Viral Clearance market.
Method Outlook (Revenue, USD Million; 2018-2028)
Chromatography
Nanofiltration
Precipitation
Low pH
Solvent Detergent Method
Pasteurization
Other Viral Inactivation Methods
Application Outlook (Revenue, USD Million; 2018-2028)
Recombinant Proteins
Blood and Blood Products
Vaccines
Other Applications
End-use Outlook (Revenue, USD Million; 2018-2028)
Pharmaceutical Biotechnology Companies
Contract Research Organizations (CROs)
Academic Research Institutes
Others
Read More Reports –
Whole Exome Sequencing Market - https://www.reportsanddata.com/report-detail/whole-exome-sequencing-market
Multiparameter Patient Monitoring Market - https://www.reportsanddata.com/report-detail/multiparameter-patient-monitoring-market
Biotechnology Market - https://www.reportsanddata.com/report-detail/biotechnology-market
Tissue Engineering Market - https://www.reportsanddata.com/report-detail/tissue-engineering-market
Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
